Selected research
Market Analysis & Forecast
Global Filgrastim Market Analysis and Forecast 2026-2032
Market perspective
The global Filgrastim market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Filgrastim is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Filgrastim is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Filgrastim is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Filgrastim is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Filgrastim include SANDOZ INC, Amgen and Teva, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Filgrastim, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Filgrastim, also provides the sales of main regions and countries. Of the upcoming market potential for Filgrastim, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Filgrastim sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Filgrastim market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Filgrastim sales, projected growth trends, production technology, application and end-user industry.
Filgrastim Segment by Company
SANDOZ INC
Amgen
Teva
Filgrastim Segment by Type
Lyophilized Powder
Others
Filgrastim Segment by Application
Solid Tumor
Kidney Cancer
Lymphoma
Lung Disease
Others
Filgrastim Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgrastim market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Filgrastim and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgrastim.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Filgrastim in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Filgrastim manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Filgrastim sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lyophilized Powder
- Others
Applications
- Solid Tumor
- Kidney Cancer
- Lymphoma
- Lung Disease
- Others
Companies covered
- SANDOZ INC
- Amgen
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Filgrastim Market by Type
- 1.2.1 Global Filgrastim Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Lyophilized Powder
- 1.2.3 Others
- 1.3 Filgrastim Market by Application
- 1.3.1 Global Filgrastim Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Solid Tumor
- 1.3.3 Kidney Cancer
- 1.3.4 Lymphoma
- 1.3.5 Lung Disease
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Filgrastim Market Dynamics
- 2.1 Filgrastim Industry Trends
- 2.2 Filgrastim Industry Drivers
- 2.3 Filgrastim Industry Opportunities and Challenges
- 2.4 Filgrastim Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Filgrastim Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Filgrastim Revenue by Region
- 3.2.1 Global Filgrastim Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Filgrastim Revenue by Region (2021-2026)
- 3.2.3 Global Filgrastim Revenue by Region (2027-2032)
- 3.2.4 Global Filgrastim Revenue Market Share by Region (2021-2032)
- 3.3 Global Filgrastim Sales Estimates and Forecasts 2021-2032
- 3.4 Global Filgrastim Sales by Region
- 3.4.1 Global Filgrastim Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Filgrastim Sales by Region (2021-2026)
- 3.4.3 Global Filgrastim Sales by Region (2027-2032)
- 3.4.4 Global Filgrastim Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Filgrastim Revenue by Manufacturers
- 4.1.1 Global Filgrastim Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Filgrastim Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Filgrastim Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Filgrastim Sales by Manufacturers
- 4.2.1 Global Filgrastim Sales by Manufacturers (2021-2026)
- 4.2.2 Global Filgrastim Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Filgrastim Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Filgrastim Sales Price by Manufacturers (2021-2026)
- 4.4 Global Filgrastim Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Filgrastim Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Filgrastim Manufacturers, Product Type & Application
- 4.7 Global Filgrastim Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Filgrastim Market CR5 and HHI
- 4.8.2 2025 Filgrastim Tier 1, Tier 2, and Tier 3
5 Filgrastim Market by Type
- 5.1 Global Filgrastim Revenue by Type
- 5.1.1 Global Filgrastim Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Filgrastim Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Filgrastim Revenue Market Share by Type (2021-2032)
- 5.2 Global Filgrastim Sales by Type
- 5.2.1 Global Filgrastim Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Filgrastim Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Filgrastim Sales Market Share by Type (2021-2032)
- 5.3 Global Filgrastim Price by Type
6 Filgrastim Market by Application
- 6.1 Global Filgrastim Revenue by Application
- 6.1.1 Global Filgrastim Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Filgrastim Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Filgrastim Revenue Market Share by Application (2021-2032)
- 6.2 Global Filgrastim Sales by Application
- 6.2.1 Global Filgrastim Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Filgrastim Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Filgrastim Sales Market Share by Application (2021-2032)
- 6.3 Global Filgrastim Price by Application
7 Company Profiles
- 7.1 SANDOZ INC
- 7.1.1 SANDOZ INC Company Information
- 7.1.2 SANDOZ INC Business Overview
- 7.1.3 SANDOZ INC Filgrastim Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 SANDOZ INC Filgrastim Product Portfolio
- 7.1.5 SANDOZ INC Recent Developments
- 7.2 Amgen
- 7.2.1 Amgen Company Information
- 7.2.2 Amgen Business Overview
- 7.2.3 Amgen Filgrastim Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Amgen Filgrastim Product Portfolio
- 7.2.5 Amgen Recent Developments
- 7.3 Teva
- 7.3.1 Teva Company Information
- 7.3.2 Teva Business Overview
- 7.3.3 Teva Filgrastim Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Teva Filgrastim Product Portfolio
- 7.3.5 Teva Recent Developments
8 North America
- 8.1 North America Filgrastim Market Size by Type
- 8.1.1 North America Filgrastim Revenue by Type (2021-2032)
- 8.1.2 North America Filgrastim Sales by Type (2021-2032)
- 8.1.3 North America Filgrastim Price by Type (2021-2032)
- 8.2 North America Filgrastim Market Size by Application
- 8.2.1 North America Filgrastim Revenue by Application (2021-2032)
- 8.2.2 North America Filgrastim Sales by Application (2021-2032)
- 8.2.3 North America Filgrastim Price by Application (2021-2032)
- 8.3 North America Filgrastim Market Size by Country
- 8.3.1 North America Filgrastim Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Filgrastim Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Filgrastim Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Filgrastim Market Size by Type
- 9.1.1 Europe Filgrastim Revenue by Type (2021-2032)
- 9.1.2 Europe Filgrastim Sales by Type (2021-2032)
- 9.1.3 Europe Filgrastim Price by Type (2021-2032)
- 9.2 Europe Filgrastim Market Size by Application
- 9.2.1 Europe Filgrastim Revenue by Application (2021-2032)
- 9.2.2 Europe Filgrastim Sales by Application (2021-2032)
- 9.2.3 Europe Filgrastim Price by Application (2021-2032)
- 9.3 Europe Filgrastim Market Size by Country
- 9.3.1 Europe Filgrastim Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Filgrastim Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Filgrastim Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Filgrastim Market Size by Type
- 10.1.1 China Filgrastim Revenue by Type (2021-2032)
- 10.1.2 China Filgrastim Sales by Type (2021-2032)
- 10.1.3 China Filgrastim Price by Type (2021-2032)
- 10.2 China Filgrastim Market Size by Application
- 10.2.1 China Filgrastim Revenue by Application (2021-2032)
- 10.2.2 China Filgrastim Sales by Application (2021-2032)
- 10.2.3 China Filgrastim Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Filgrastim Market Size by Type
- 11.1.1 Asia Filgrastim Revenue by Type (2021-2032)
- 11.1.2 Asia Filgrastim Sales by Type (2021-2032)
- 11.1.3 Asia Filgrastim Price by Type (2021-2032)
- 11.2 Asia Filgrastim Market Size by Application
- 11.2.1 Asia Filgrastim Revenue by Application (2021-2032)
- 11.2.2 Asia Filgrastim Sales by Application (2021-2032)
- 11.2.3 Asia Filgrastim Price by Application (2021-2032)
- 11.3 Asia Filgrastim Market Size by Country
- 11.3.1 Asia Filgrastim Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Filgrastim Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Filgrastim Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Filgrastim Market Size by Type
- 12.1.1 SAMEA Filgrastim Revenue by Type (2021-2032)
- 12.1.2 SAMEA Filgrastim Sales by Type (2021-2032)
- 12.1.3 SAMEA Filgrastim Price by Type (2021-2032)
- 12.2 SAMEA Filgrastim Market Size by Application
- 12.2.1 SAMEA Filgrastim Revenue by Application (2021-2032)
- 12.2.2 SAMEA Filgrastim Sales by Application (2021-2032)
- 12.2.3 SAMEA Filgrastim Price by Application (2021-2032)
- 12.3 SAMEA Filgrastim Market Size by Country
- 12.3.1 SAMEA Filgrastim Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Filgrastim Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Filgrastim Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Filgrastim Value Chain Analysis
- 13.1.1 Filgrastim Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Filgrastim Production Mode & Process
- 13.2 Filgrastim Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Filgrastim Distributors
- 13.2.3 Filgrastim Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst